Interestingly, a metastatic non-small-cell lung cancer (NSCLC) case harboring PTEN mutation, PD-L1 positivity, and high tumor mutation burden showed a lack of durable response to PD-1 inhibitor [87]. Here, CD274 is linked to non-small cell lung carcinoma.